Hyplaxy (Hydroxychloroquine Sulfate)

Hydroxychloroquine accumulates in acidic organelles such as lysosomes, raising their pH. This change interferes with antigen processing, lysosomal enzyme activity, and the replication of intracellular parasites. In autoimmune conditions, the altered pH also dampens immune cell activation and cytokine release, providing both antimalarial and immunomodulatory effects.

The dosage of Hyplaxy is individualized by the prescribing healthcare professional based on the specific indication, patient weight, renal and hepatic function, and other clinical factors. Physicians determine the appropriate amount and schedule, and patients should follow the exact regimen provided on the prescription label.

Hydroxychloroquine sulfate is classified as Pregnancy Category B, indicating that animal studies have not shown fetal risk, but adequate human data are limited. It may be used during pregnancy or lactation only when the potential benefit justifies any possible risk to the fetus or infant, and under close medical supervision.

To request Hyplaxy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

The most common alternative to hydroxychloroquine is chloroquine, which shares a similar mechanism but has a narrower therapeutic window and higher toxicity risk. Compared with other disease‑modifying antirheumatic drugs such as methotrexate, hydroxychloroquine offers a milder immunosuppressive profile and is often used when patients cannot tolerate stronger agents.

Hyplaxy should be stored at temperatures below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product in a dry place, away from excessive heat, and ensure the container is tightly closed when not in use to maintain stability.

Hyplaxy is taken orally, usually with a full glass of water. It may be taken with or without food, depending on the prescriber’s advice. Patients should swallow the tablet whole and avoid crushing or chewing it unless specifically instructed by a healthcare professional.

The most serious adverse effects include retinal toxicity, which can lead to irreversible vision loss and requires regular ophthalmologic monitoring; cardiac complications such as QT‑interval prolongation and cardiomyopathy; severe hypoglycemia, especially in diabetic patients; and hemolytic anemia in individuals with glucose‑6‑phosphate dehydrogenase deficiency.

Hyplaxy is contraindicated in patients with known hypersensitivity to hydroxychloroquine or related compounds, those with pre‑existing retinal disease, severe renal or hepatic impairment without appropriate monitoring, and individuals with glucose‑6‑phosphate dehydrogenase deficiency due to the risk of hemolysis. Consultation with a healthcare provider is essential before initiating therapy.